Pleural plaque

J10_PLEURPLAGUE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J92 Cause of death: ICD-10 — J92 2 out of 7 registries used, show all original rules.	3751
4. Check minimum number of events None	3751
5. Include endpoints None	3751
6. Filter based on genotype QC (FinnGen only)	3751

Control definitions (FinnGen only)

Control exclude: J10_PLEURA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J90-J94
Name in latin: Lamellae pleurae

NAME	J10_PLEURPLAGUE
CONTROL_EXCLUDE	J10_PLEURA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J92
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J92
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pleural plaque based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22511	3209	19103
Only index persons	19742	2946	16796
Unadjusted period prevalence (%)
Whole population	0.47	0.09	0.53
Only index persons	0.56	0.11	0.64
Median age at first event (years)
Whole population	70.41	72.57	70.00
Only index persons	69.71	72.31	69.25

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3751	393	3358
Unadjusted period prevalence (%)	1.34	0.13	1.48
Median age at first event (years)	69.69	69.12	69.75

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3371: Matched controls
33710

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

4667.1

323.0

2458

J92.9

ICD-10 Finland

Pleural plaque without asbestos

3280.5

323.0

1177

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

6.6

323.0

1109

2336

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

202.5

323.0

362

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

13.6

323.0

716

653

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

102.2

323.0

467

R03AC02

ATC

salbutamol; inhalant

3.4

237.8

1988

10111

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.5

225.9

760

1700

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.1

211.5

997

3128

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

11.4

208.8

410

403

Z57.2

ICD-10 Finland

Occupational exposure to dust

155.8

194.9

205

R03BB04

ATC

tiotropium bromide; inhalant

4.2

192.6

866

2570

J94.8

ICD-10 Finland

Other specified pleural conditions

367.9

176.1

176

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.1

169.3

500

929

J96.1

ICD-10 Finland

Chronic respiratory failure

+∞

169.2

161

R06.0

ICD-10 Finland

Dyspnoea

3.0

165.3

1257

5526

XG410

NOMESCO Finland

Flow-volume spirometry

7.4

157.2

400

603

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.9

155.8

477

922

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

139.9

1986

12252

TGC00

NOMESCO Finland

Bronchial lavation

8.2

112.1

263

345

H02AB06

ATC

prednisolone; systemic

2.2

107.2

1784

11266

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

7.6

104.1

255

357

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

29.6

96.4

131

J45.9

ICD-10 Finland

Asthma, unspecified

2.8

96.2

730

3021

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.6

94.4

836

3785

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

7.7

92.6

224

307

J92

ICD-10 Finland

Pleural plaque

+∞

83.7

R05

ICD-10 Finland

Cough

2.5

83.2

760

3467

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.7

80.0

642

2713

GD1AD

NOMESCO Finland

Thorax CT examination

4.6

79.4

294

683

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.7

77.6

371

1091

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.5

70.6

220

422

J45.1

ICD-10 Finland

Nonallergic asthma

3.7

70.1

335

981

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.3

65.3

356

1155

J98.1

ICD-10 Finland

Pulmonary collapse

140.8

65.1

J94.9

ICD-10 Finland

Pleural condition, unspecified

+∞

60.6

R03BA08

ATC

ciclesonide; inhalant

3.6

60.4

294

871

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

6.0

59.1

171

299

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

+∞

58.5

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.2

57.9

235

594

R03AK07

ATC

formoterol and budesonide; inhalant

2.4

57.5

582

2741

XX1XW

NOMESCO Finland

Extensive written report from radiologist

5.9

53.8

156

274

J96.0

ICD-10 Finland

Acute respiratory failure

186.2

53.1

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

113.8

51.9

GAC00

NOMESCO Finland

Biopsy of pleura

56.4

51.7

J01AA02

ATC

doxycycline; systemic

1.8

51.6

2431

19855

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.7

50.8

389

1569

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

50.2

1163

7590

R03BA05

ATC

fluticasone; inhalant

2.2

48.0

555

2764

TGA30

NOMESCO Finland

Thoracocentesis

21.0

45.8

R03BA01

ATC

beclometasone; inhalant

2.3

44.6

484

2332

R02

ICPC

Shortness of breath/dyspnoea

2.3

43.8

474

2280

A02BC02

ATC

pantoprazole; systemic

1.6

41.8

2066

16503

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

8.4

40.1

110

SPAT1263

SPAT

Sampling

1.7

40.0

1384

9993

J01CA04

ATC

amoxicillin; systemic

1.6

38.6

2284

18928

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.9

36.8

157

415

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

8.6

36.3

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

4.5

35.3

128

290

C45.0

ICD-10 Finland

Mesothelioma of pleura

40.5

35.3

R03AK08

ATC

formoterol and beclometasone; inhalant

4.2

34.7

135

328

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

34.3

689

4191

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

6.5

34.3

143

R04.2

ICD-10 Finland

Haemoptysis

2.9

34.2

223

811

N02BE01

ATC

paracetamol; systemic, rectal

1.7

34.0

2687

23561

R95

ICPC

Chron obstructive pulmonary disease

3.3

33.7

181

576

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.7

33.4

117

256

R06.2

ICD-10 Finland

Wheezing

3.3

32.4

169

526

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

32.3

583

3413

XG474

NOMESCO Finland

Exhalation nntrogen oxide

5.1

32.0

103

206

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

72.9

31.9

5119X

ICD-9 Finland

Pleurisy, Unspecified pleural effusion

+∞

31.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

31.2

1301

9666

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

8.5

31.2

R03BA02

ATC

budesonide; inhalant

1.9

31.0

490

2734

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

156.3

29.7

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.3

29.6

113

270

R05

ICPC

Cough

1.8

29.1

624

3855

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

28.8

694

4439

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

5.3

28.7

171

J47

ICD-10 Finland

Bronchiectasis

4.2

28.5

110

266

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.5

27.8

133

388

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.9

27.6

172

607

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

27.5

271

1237

C03CA01

ATC

furosemide; systemic

1.5

27.5

1314

9985

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

27.1

1422

11019

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

26.8

867

5993

R03AC13

ATC

formoterol; inhalant

2.7

26.2

185

707

SPAT1312

SPAT

General health counselling

1.6

26.2

952

6771

J01MA14

ATC

moxifloxacin; systemic

2.1

26.0

316

1583

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

251.9

24.7

R03BB01

ATC

ipratropium bromide; inhalant

2.5

24.6

207

869

SPAT1301

SPAT

No procedures

1.5

24.3

1078

7998

SPAT1058

SPAT

PEF monitoring instruction

2.1

23.3

279

1389

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

23.1

193

810

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.6

23.1

124

R01AD09

ATC

mometasone; nasal

1.5

22.5

973

7154

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

22.2

1253

9731

R03AC03

ATC

terbutaline; inhalant

1.9

22.1

355

1980

G47.3

ICD-10 Finland

Sleep apnoea

1.6

21.8

656

4421

SPAT1310

SPAT

Counselling related to known health issue

1.5

21.6

975

7218

R96

ICPC

Asthma

2.1

21.4

250

1232

SPAT1325

SPAT

Vaccination

1.4

21.3

1291

10144

A02BC05

ATC

esomeprazole; systemic

1.5

20.8

1112

8512

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

20.4

340

1920

M03BX02

ATC

tizanidine; oral

1.4

20.4

1389

11131

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

20.2

944

7017

J01FA06

ATC

roxithromycin; oral

1.5

20.2

1062

8090

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

20.2

385

2272

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

19.9

676

4679

R03DC03

ATC

montelukast; oral

1.9

19.9

326

1830

J43.9

ICD-10 Finland

Emphysema, unspecified

3.5

19.6

277

R03AK11

ATC

formoterol and fluticasone; inhalant

3.9

19.6

211

L03

ICPC

Low back symptom/complaint

1.6

19.5

574

3833

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.3

19.5

181

804

J01DB01

ATC

cefalexin; oral

1.4

19.3

2358

20904

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.9

19.1

116

404

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.5

18.9

155

J43.2

ICD-10 Finland

Centrilobular emphysema

10.7

18.9

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.0

18.6

186

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

18.6

1269

10121

J93.9

ICD-10 Finland

Pneumothorax, unspecified

190.9

18.5

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

18.5

870

6455

J45.8

ICD-10 Finland

Mixed asthma

3.1

18.0

323

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

18.0

1098

8564

SPAT1153

SPAT

Removal of sutures

1.4

17.8

1074

8354

J98.6

ICD-10 Finland

Disorders of diaphragm

+∞

17.7

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.8

17.7

117

431

XG466

NOMESCO Finland

Sleep oxymetry

2.7

17.5

121

458

R03AC18

ATC

indacaterol; inhalant

5.1

17.4

110

C07AB07

ATC

bisoprolol; oral

1.4

17.1

1776

15133

L08

ICPC

Shoulder symptom/complaint

1.6

17.0

529

3571

M54.5

ICD-10 Finland

Low back pain

1.5

17.0

768

5636

A02BC03

ATC

lansoprazole; oral

1.4

16.7

872

6581

J96.9

ICD-10 Finland

Respiratory failure, unspecified

35.2

16.7

N02AX02

ATC

tramadol; systemic, rectal

1.4

16.3

1315

10717

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

16.2

856

6471

J01MA12

ATC

levofloxacin; systemic

1.5

16.2

675

4864

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.8

16.2

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

16.1

805

6015

A98

ICPC

Health maint/preventive medicine

1.4

16.0

2731

25168

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.6

15.9

199

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

15.5

738

5456

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

15.5

349

2160

N06AX11

ATC

mirtazapine; oral

1.4

15.4

747

5544

XG405

NOMESCO Finland

Education on PEF monitoring

4.0

15.4

159

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.2

15.4

9050/3-C38.4

ICD-O-3

Mesothelioma, malignant of pleura, NOS

38.2

15.4

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

5.9

15.2

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

15.2

955

7433

SPAT1254

SPAT

Administration of medicine

1.5

15.0

494

3372

R03DA04

ATC

theophylline; systemic, rectal

1.9

14.9

231

1269

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

14.8

702

5179

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

6.9

14.6

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

14.6

1041

8277

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

14.5

321

1978

J45

ICD-10 Finland

Asthma

1.9

14.4

219

1196

M01AC06

ATC

meloxicam; systemic, rectal

1.4

14.4

864

6664

J01FA15

ATC

telithromycin; oral

1.9

14.3

209

1124

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

14.3

865

6678

F1246

NOMESCO Finland

17.0

14.3

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

14.2

1092

8775

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.0

14.2

142

G04CA02

ATC

tamsulosin; oral

1.3

14.1

1430

11999

R99

ICPC

Respiratory disease other

3.3

14.0

215

R01AD12

ATC

fluticasone furoate; nasal

1.5

13.9

491

3405

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

13.9

1134

9194

J01FA09

ATC

clarithromycin; systemic

1.4

13.8

656

4839

SPAT1097

SPAT

Recording of ECG

1.5

13.6

524

3700

C10AA01

ATC

simvastatin; oral

1.3

13.5

1763

15311

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

13.5

984

7825

A02BC01

ATC

omeprazole; systemic

1.4

13.5

863

6717

M01AH05

ATC

etoricoxib; oral

1.3

13.4

1323

11029

SPAT1059

SPAT

Spirometry at the office

2.0

13.4

177

919

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

13.3

145

695

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

13.2

165

837

J98.4

ICD-10 Finland

Other disorders of lung

40.2

13.1

TGD00

NOMESCO Finland

Needle biopsy of lung

6.2

13.0

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

12.9

112

484

R03BB07

ATC

umeclidinium bromide; inhalant

4.8

12.8

I50.0

ICD-10 Finland

Congestive heart failure

1.6

12.8

336

2164

M79.6

ICD-10 Finland

Pain in limb

1.4

12.7

870

6835

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

12.7

890

7017

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

12.7

1109

9059

R06AE07

ATC

cetirizine; oral

1.4

12.5

863

6785

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

12.5

586

4302

H02AB04

ATC

methylprednisolone; systemic

1.6

12.4

371

2473

SPAT1260

SPAT

Consultation of another employee

1.5

12.3

531

3833

J43.8

ICD-10 Finland

Other emphysema

8.4

12.2

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

4.6

12.1

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.2

12.1

123

573

C01DA14

ATC

isosorbide mononitrate; oral

1.4

12.1

792

6167

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

12.0

512

3684

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.8

11.9

264

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

11.7

1571

13581

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

8.9

11.7

J42

ICD-10 Finland

Unspecified chronic bronchitis

3.4

11.7

168

UJF32

NOMESCO Finland

Coloscopy

1.4

11.7

810

6364

J20

ICD-10 Finland

Acute bronchitis

1.7

11.7

232

1386

R29

ICPC

Respiratory symptom/complaint other

2.0

11.6

155

809

Y96.0

ICD-10 Finland

Work-related condition

8.1

11.5

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

11.5

928

7462

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

11.5

455

3227

J94.1

ICD-10 Finland

Fibrothorax

+∞

11.5

51101

ICD-8 Finland

Pleurisy, Adhaesiones pleurae

+∞

11.5

R03AC19

ATC

olodaterol; inhalant

5.9

11.5

J46

ICD-10 Finland

Status asthmaticus

2.8

11.4

261

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

11.4

298

1920

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

11.3

834

6610

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

7.0

11.3

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

11.2

713

5519

R06AX27

ATC

desloratadine; oral

1.5

11.2

397

2751

XX1VW

NOMESCO Finland

Written report from radiologist

4.8

11.1

SPAT1053

SPAT

Memory test

1.4

11.1

690

5318

M01AE02

ATC

naproxen; oral, rectal

1.3

11.0

1327

11275

E0000UV

ATC

1.3

11.0

962

7818

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

11.0

127

628

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

10.9

611

4622

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

10.9

221

1326

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

10.8

2350

21540

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

10.7

978

7995

N03AX16

ATC

pregabalin; oral

1.4

10.6

591

4466

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

10.6

305

2015

AA1AD

NOMESCO Finland

CT of head and brain

1.3

10.6

828

6615

SPAT1211

SPAT

Application of soft bandage

1.6

10.5

268

1715

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

4.1

10.5

S18

ICPC

Laceration/cut

1.3

10.4

1306

11134

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

10.4

624

4780

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

10.2

342

2334

SPAT1043

SPAT

Audiometry

1.5

10.2

391

2748

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

10.2

125

631

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

10.1

1019

8426

XQ800

NOMESCO Finland

Prick test

2.2

10.0

103

483

R03AC12

ATC

salmeterol; inhalant

1.9

10.0

150

820

C10AA05

ATC

atorvastatin; oral

1.3

9.9

1397

12059

D07AC13

ATC

mometasone; topical

1.3

9.9

745

5905

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

9.9

529

3964

XF402

NOMESCO Finland

ECG with work load test

1.5

9.9

390

2759

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

12.2

9.8

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

3.0

9.8

181

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

9.8

204

1237

207

Kela drug reimbursment

Chronic arrhythmias

1.4

9.7

610

4698

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

9.7

625

4838

M01AB05

ATC

diclofenac; systemic, rectal

1.3

9.6

1686

14930

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

5.0

9.5

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

10.0

9.5

J93.8

ICD-10 Finland

Other pneumothorax

100.3

9.4

9052/3-C38.4

ICD-O-3

Epithelioid mesothelioma, malignant of pleura, NOS

100.3

9.4

R03BB05

ATC

aclidinium bromide; inhalant

7.5

9.4

WX721

NOMESCO Finland

Oxygen concentrator therapy

17.6

9.4

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

9.4

303

2054

WX110

NOMESCO Finland

Local anesthesy

1.3

9.4

1674

14840

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

9.3

1362

11780

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

9.3

489

3650

R28

ICPC

Limited function/disability (R)

3.0

9.3

166

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

5.2

9.2

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

9.1

629

4914

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

9.1

1707

15189

L01

ICPC

Neck symptom/complaint

1.6

9.1

269

1785

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

7.0

9.0

J01FA10

ATC

azithromycin; systemic

1.3

9.0

1087

9178

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

9.0

251

1643

R42

ICD-10 Finland

Dizziness and giddiness

1.3

9.0

643

5050

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

8.9

311

2143

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

8.9

185

1121

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

8.7

784

6364

AN1

Coronary angiography

1.4

8.7

524

4006

J62.0

ICD-10 Finland

Pneumoconiosis due to talc dust

14.0

8.7

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

8.6

1027

8643

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.0

8.6

158

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

3.8

8.6

P01BA02

ATC

hydroxychloroquine; oral

1.8

8.6

155

902

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

27.6

8.5

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

8.5

1325

11514

J01DA01

ATC

[U] cefalexin; systemic

1.2

8.4

1694

15139

J94.2

ICD-10 Finland

Haemothorax

90.2

8.4

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

8.4

412

3038

51120

ICD-8 Finland

Pleurisy, Other specified forms of effusion, except tuberculous

+∞

8.3

R07.3

ICD-10 Finland

Other chest pain

1.5

8.3

250

1668

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

8.5

8.3

C09CA06

ATC

candesartan; oral

1.3

8.2

543

4209

R13

ICD-10 Finland

Dysphagia

1.6

8.2

200

1268

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

8.2

382

2793

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

3.2

8.1

131

R53

ICD-10 Finland

Malaise and fatigue

1.3

8.1

551

4289

RS150

NOMESCO Finland

33.4

8.1

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

6.8

8.0

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

8.0

430

3222

L01CA04

ATC

vinorelbine; systemic

3.7

8.0

L17

ICPC

Foot/toe symptom/complaint

1.3

8.0

657

5260

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

8.0

194

1229

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

8.0

378

2771

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

7.9

559

4377

UDC00

NOMESCO Finland

Ear microscopy

1.6

7.9

206

1328

M02AA07

ATC

piroxicam; topical

1.3

7.9

968

8158

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.0

7.8

462

R78

ICPC

Acute bronchitis/bronchiolitis

2.5

7.8

236

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

7.7

1082

9260

R81

ICPC

Pneumonia

1.9

7.7

102

535

R05FB02

ATC

cough suppressants and expectorants

1.3

7.7

1027

8744

E000001

ATC

1.4

7.7

472

3618

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

5.9

7.7

XKD00

NOMESCO Finland

Uroflowmetry

1.3

7.7

868

7242

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

7.6

126

714

GAA31

NOMESCO Finland

Thoracoscopy

6.7

7.6

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

7.5

418

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

7.5

540

4238

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

4.6

7.5

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

7.5

490

3790

D14.3

ICD-10 Finland

Benign neoplasm: Bronchus and lung

7.1

7.5

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

7.5

283

1987

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

7.5

237

1601

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.4

930

7850

GAC30

NOMESCO Finland

Artificial pneumothorax

80.2

7.4

JN4AD

NOMESCO Finland

Body CT examination

1.5

7.4

255

1757

M02AA10

ATC

ketoprofen; topical

1.4

7.4

371

2750

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

7.4

452

3463

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

7.3

109

597

WZA90

NOMESCO Finland

Other doctors statement

1.3

7.3

488

3789

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

7.3

2062

18977

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

7.2

197

1285

A02BA02

ATC

ranitidine; systemic

1.3

7.1

598

4790

D07AC01

ATC

betamethasone; topical

1.3

7.1

907

7661

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.8

7.1

120

684

A01AB09

ATC

miconazole; local oral

1.6

7.1

199

1307

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.9

7.0

138

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

7.0

355

2636

R21

ICPC

Throat symptom/complaint

1.5

7.0

253

1761

284

Kela drug reimbursment

Nintedanib and pirfenidone

3.6

6.9

L04AA13

ATC

leflunomide; oral

2.6

6.9

183

WX722

NOMESCO Finland

PEEP

1.7

6.9

149

915

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.2

6.9

103

356

Kela drug reimbursment

Nintedanib and pirfenidone

3.9

6.8

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

6.8

217

1470

GX1K5

NOMESCO Finland

Diffusion capacity

8.3

6.8

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

8.3

6.8

F2680

NOMESCO Finland

8.3

6.8

J62.8

ICD-10 Finland

Pneumoconiosis due to other dust containing silica

9.3

6.8

M48.0

ICD-10 Finland

Spinal stenosis

1.4

6.8

397

3016

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

6.7

510

4026

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

6.7

268

1900

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

6.7

397

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.6

6.7

165

1049

Z51.5

ICD-10 Finland

Palliative care

1.5

6.7

218

1485

A07AA02

ATC

nystatin; oral

1.6

6.7

157

989

N07BA03

ATC

varenicline; oral

2.1

6.7

362

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.8

6.6

101

557

H13

ICPC

Plugged feeling ear

1.3

6.6

614

4982

R01AD08

ATC

fluticasone; nasal

1.3

6.6

534

4255

I50

ICD-10 Finland

Heart failure

1.7

6.6

123

724

SPAT1101

SPAT

Orthostatic test

1.6

6.6

158

998

348

Kela drug reimbursment

Roflumilast

5.5

6.6

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

6.5

106

599

J01FF01

ATC

clindamycin; systemic

1.3

6.5

668

5496

GAC37

NOMESCO Finland

Endoscopic chemical pleurodesis

70.0

6.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

6.4

751

6272

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.4

6.4

272

1954

G04CA01

ATC

alfuzosin; oral

1.3

6.4

618

5046

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

6.3

178

1172

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.5

6.3

196

1322

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

6.3

206

1404

1240

FHL

Bronchoscopy

2.4

6.3

207

TGA10

NOMESCO Finland

Needle biopsy of pleura

26.7

6.2

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

6.2

246

1746

B01AA03

ATC

warfarin; systemic

1.2

6.2

889

7596

N03AX12

ATC

gabapentin; oral

1.4

6.1

353

2672

SPAT1262

SPAT

Handing over of treatment supplies

1.3

6.1

608

4975

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.1

6.1

7170A

ICD-9 Finland

Internal derangement of knee, Old bucket handle tear of medial meniscus

1.9

6.1

444

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

6.1

212

1465

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.7

6.1

126

768

N02AA01

ATC

morphine; systemic, rectal

2.2

6.0

257

A06AD11

ATC

lactulose; oral

1.3

6.0

511

4099

D38.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pleura

6.7

6.0

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

6.0

594

4858

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

421

1209

3.80

125.93

3.0

2.6

—

(4010399)

547

1959

3.10

114.82

1.5

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

128

134

9.85

109.94

1.3

1.1

u/l

13.7

14.2

0.07

119

112

(3042631) Mycobacterium sp identified in Specimen

212

453

4.90

93.03

3.0

2.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

17.12

77.31

1.4

1.1

ug/l

48.8

824.5

0.49

(3013115) Eosinophils [#/volume] in Blood

2042

14567

1.88

76.19

5.6

5.4

e9/l

0.2

0.18

1822

12444

(3003434) Protein [Mass/volume] in Pleural fluid

167

348

4.98

75.37

1.4

1.2

g/l

35.6

27.4

12.02

155

285

(42870588) Differential panel, method unspecified - Blood

1536

10056

1.89

74.50

5.8

5.3

—

(3001604) Monocytes [#/volume] in Blood

1979

14057

1.86

74.02

5.4

5.2

e9/l

0.7

5.15

1734

11842

(3006315) Basophils [#/volume] in Blood

1987

14165

1.86

73.12

5.4

5.2

e9/l

0.0

1.07

1745

11961

(40768806) Pleura Pathology biopsy report

131

229

5.89

71.74

1.6

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

1992

14371

1.82

68.93

5.5

5.4

e9/l

1.8

1.9

0.53

1779

12302

(3012441) Differential panel - Pleural fluid

133

249

5.50

67.71

1.4

1.2

—

(3023419) Bacteria identified in Sputum by Culture

169

392

4.47

66.89

2.5

2.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

226

657

3.60

65.47

1.6

1.4

—

(3019060) Gas panel - Arterial blood

529

2470

2.33

63.18

3.9

4.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

1874

13548

1.77

61.80

6.2

5.8

24.1

25.0

3.02

1730

12353

(3023199) Leukocytes [#/volume] in Pleural fluid

145

317

4.72

61.75

1.4

1.2

e6/l

3957.3

2635.5

0.25

123

206

(3022096) Basophils/100 leukocytes in Blood

1806

12936

1.76

61.36

5.9

5.5

0.6

0.40

1679

11868

(3019069) Monocytes/100 leukocytes in Blood

1851

13356

1.76

61.26

6.4

5.9

9.4

9.1

2.54

1722

12275

(3006504) Eosinophils/100 leukocytes in Blood

1843

13287

1.76

61.13

6.0

5.6

2.9

0.27

1715

12166

(3028308) Erythrocytes [#/volume] in Pleural fluid

131

286

4.71

55.87

1.4

1.2

e6/l

146495.7

27736.0

1.74

151

(3009343) pH of Capillary blood

493

2370

2.24

54.48

4.6

3.3

7.4

0.05

275

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

167

451

3.83

53.82

1.2

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

1815

13342

1.70

53.52

5.7

5.5

60.1

59.3

1.91

1679

12244

(3035880) pH of Pleural fluid

130

6.67

53.12

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

495

2409

2.22

53.00

4.7

3.3

kpa

5.3

5.0

8.05

458

2169

(3013707) Erythrocyte sedimentation rate by Westergren method

2572

20817

1.75

52.70

5.5

4.0

mm/h

16.3

14.3

6.72

2350

18802

(3013650) Neutrophils [#/volume] in Blood by Automated count

2127

16400

1.69

51.62

7.7

8.2

e9/l

4.6

4.5

1.47

1893

14096

(3023383) Lactate [Moles/volume] in Pleural fluid

10.14

51.36

1.3

mmol/l

3.7

3.3

0.27

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

472

2281

2.22

51.33

4.6

3.3

mmol/l

2.1

1.4

3.02

378

1600

(3000492) Spirometry study

407

1874

2.31

49.63

1.7

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

183

5.41

48.96

3.7

3.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1633

11877

1.66

48.54

3.8

3.2

ng/l

1706.4

1972.6

2.07

1428

10394

(3022313) Gas panel - Capillary blood

378

1710

2.35

47.95

4.7

3.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

269

1054

2.67

46.34

1.3

u/ml

329.9

327.3

0.01

250

945

(3036782) Glucose [Moles/volume] in Pleural fluid

103

223

4.72

44.38

1.3

1.2

mmol/l

6.0

7.1

2.67

207

(3032080) INR in Blood by Coagulation assay

1974

15271

1.62

44.35

13.5

12.0

inr

1.4

0.48

609

4037

(3037522) Nuclear Ab [Titer] in Serum

512

2728

2.02

42.66

1.3

1.2

titre

445.2

426.0

0.10

132

559

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1758

13317

1.60

42.38

5.2

4.2

ng/l

49.7

82.5

1.51

1491

10829

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2051

16162

1.59

41.48

6.2

umol/l

13.0

13.2

0.25

1919

15322

(1616796) Gas panel - Central venous blood

211

775

2.83

41.11

4.0

3.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

853

5403

1.75

41.10

5.0

4.5

—

(3012501) Base excess in Blood by calculation

202

743

2.82

39.24

4.8

3.8

mmol/l

2.6

2.4

0.63

145

464

(3013290) Carbon dioxide [Partial pressure] in Blood

202

743

2.82

39.24

4.8

3.8

kpa

5.0

4.8

2.09

196

724

(3027315) Oxygen [Partial pressure] in Blood

202

746

2.80

38.94

4.8

3.8

kpa

8.1

8.4

2.10

196

726

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

313

1440

2.28

37.92

5.3

3.7

mmol/l

25.1

24.5

2.91

290

1295

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1901

14941

1.55

37.18

6.3

6.0

mmol/l

1.2

0.48

1683

13358

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2686

22927

1.60

35.68

8.4

7.6

u/l

82.3

81.7

0.19

2527

21415

(3001893) Eosinophils/100 leukocytes in Pleural fluid

7.66

35.67

1.4

1.2

2.2

2.3

0.01

(3010421) pH of Blood

215

865

2.58

35.00

4.8

3.8

7.4

0.07

196

727

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

913

6118

1.65

34.85

2.1

1.8

—

(3003396) Base excess in Arterial blood by calculation

694

4335

1.74

34.42

5.9

6.4

mmol/l

1.7

0.8

6.75

549

3239

(40761536) Microorganisms panel - Urine sediment

448

2450

1.94

34.22

4.4

4.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

692

4346

1.73

33.58

5.9

6.4

kpa

5.2

5.0

4.69

661

4114

(3027801) Oxygen [Partial pressure] in Arterial blood

691

4345

1.72

33.36

5.9

6.4

kpa

10.8

11.9

9.07

664

4108

(3015171) Extractable nuclear Ab [Units/volume] in Serum

177

662

2.76

33.30

1.2

1.1

u/ml

0.3

0.01

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1299

9572

1.55

32.76

2.8

2.6

u/l

60.4

59.6

0.16

1177

8802

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

6.26

32.58

1.4

1.2

74.6

63.0

1.34

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2023

16405

1.51

32.24

6.8

6.9

mmol/l

1.2

0.47

1579

13768

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

558

3373

1.77

30.76

1.2

iu/ml

45.9

41.5

0.21

171

956

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

185

740

2.58

30.46

1.7

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

190

773

2.54

30.20

1.7

1.4

—

(3016502) Oxygen saturation in Arterial blood

628

3976

1.70

29.20

5.9

6.6

94.7

95.5

2.27

611

3809

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

151

558

2.78

29.07

1.7

1.5

—

(44786800) Granulocytes/100 leukocytes in Body fluid

13.59

28.80

1.3

1.2

13.7

23.9

0.69

(3020630) Protein [Mass/volume] in Serum or Plasma

515

3109

1.76

28.37

2.2

2.6

g/l

67.0

66.0

2.21

457

2761

(3045788) Cell count panel - Pleural fluid

256

3.62

27.69

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

517

3163

1.74

27.09

1.2

u/ml

15.3

16.3

0.08

154

1023

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

136

494

2.82

27.06

3.1

3.3

59.8

59.2

0.17

136

494

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

127

446

2.91

26.88

1.6

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1902

15564

1.45

26.81

3.6

3.2

u/l

59.3

59.2

0.01

1677

13943

(3013512) EKG study

1322

10118

1.47

26.32

5.3

4.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

414

2431

1.79

24.91

6.3

6.5

mmol/l

24.9

24.0

5.31

396

2266

(3013826) Glucose [Moles/volume] in Serum or Plasma

2245

19091

1.44

24.82

5.5

4.9

mmol/l

6.9

7.0

1.35

2135

17982

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

213

1007

2.18

24.02

1.5

1.7

u/l

35.6

37.3

0.56

186

833

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3033

27426

1.55

23.99

22.6

18.2

mg/l

27.4

30.3

4.76

2683

22817

(3037467) Urinalysis macro (dipstick) panel - Urine

2380

20525

1.44

23.89

5.0

4.5

—

(40767503) Oxygen content in Capillary blood by calculation

174

759

2.36

23.77

3.0

2.4

15.9

0.04

407

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

150

615

2.50

23.48

1.5

1.7

mg/l

10.8

13.4

1.75

137

557

(4015189)

5.28

23.41

1.6

1.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

309

1723

1.86

21.93

1.7

1.8

ug/l

1.3

2.7

2.36

270

1484

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

102

358

2.90

21.67

1.7

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

437

2712

1.69

21.48

3.6

3.9

mmol/l

1.2

3.04

379

2341

(3023368) Bacteria identified in Blood by Culture

1355

10727

1.41

21.26

4.6

4.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2193

18886

1.39

20.52

3.5

3.3

pmol/l

15.4

15.1

6.50

1871

16464

(3029937) Albumin [Presence] in Urine by Test strip

1052

8009

1.44

20.35

4.5

4.1

estimate

0.0

0.50

395

2390

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

150

658

2.33

20.26

1.7

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2718

24317

1.43

20.10

4.6

4.2

mu/l

2.1

0.01

2325

21346

(3031040) Bacteria [#/volume] in Urine by Automated count

2326

20264

1.39

20.07

5.4

4.8

e6/l

127.8

1383.4

2.62

392

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

593

4032

1.56

20.01

5.3

5.0

33.4

33.0

0.39

379

2617

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

275

3.06

19.54

1.6

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

379

2321

1.70

19.50

3.5

3.7

0.5

0.7

0.81

575

(3019309) Folate [Moles/volume] in Red Blood Cells

1034

7904

1.43

19.39

2.0

1.8

nmol/l

1162.8

1129.4

0.54

724

5868

(3025159) Blasts/100 leukocytes in Blood

374

2286

1.71

19.37

3.8

0.4

0.3

0.06

104

634

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

113

444

2.59

19.37

1.4

1.3

—

(40761511) CBC panel - Blood by Automated count

3028

27721

1.48

19.14

23.1

18.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

396

2479

1.67

18.73

3.7

0.2

0.1

0.59

119

776

(3017181) Myelocytes/100 leukocytes in Blood

413

2628

1.64

18.32

3.8

3.7

1.2

0.9

0.68

125

840

(3019225) pH of Specimen

521

3506

1.56

18.29

4.6

4.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

634

4466

1.50

18.01

3.4

4.0

u/l

238.8

248.5

0.97

594

4182

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

201

1038

1.99

17.93

1.6

1.5

titre

332.0

125.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

532

3616

1.55

17.84

4.7

3.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

168

817

2.11

17.65

2.4

2.1

g/l

128.6

127.4

0.19

105

603

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

114

472

2.46

17.54

1.6

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

782

5769

1.45

17.53

1.6

mg/l

1.3

1.7

3.80

623

4531

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

977

7515

1.41

17.33

1.8

pmol/l

413.4

22513670.6

4.62

735

6032

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

328

1998

1.70

17.16

6.5

mmol/l

25.1

24.4

2.32

322

1979

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

128

564

2.31

17.15

1.6

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

936

7159

1.41

17.12

3.9

3.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

197

1028

1.97

17.06

3.6

2.7

mmol/l

25.5

24.3

3.44

181

874

(3005719) IgG [Mass/volume] in Serum or Plasma

315

1916

1.70

16.56

2.4

2.6

g/l

11.0

10.8

0.39

280

1731

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

7.71

16.55

1.3

1.2

3.5

3.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

118

513

2.34

16.32

1.5

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

131

3.78

16.17

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1321

10794

1.35

15.76

4.4

4.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

351

2.60

15.72

3.6

3.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3133

29199

1.44

15.03

26.6

22.5

mmol/l

4.1

4.0

9.86

3028

28333

(3019550) Sodium [Moles/volume] in Serum or Plasma

3130

29173

1.44

14.94

26.5

22.3

mmol/l

139.3

139.6

10.30

3034

28348

(3024561) Albumin [Mass/volume] in Serum or Plasma

1680

14291

1.32

14.91

4.9

5.0

g/l

33.5

34.3

6.07

1519

13115

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3085

28685

1.43

14.86

13.2

11.3

u/l

25.0

25.4

0.38

2929

27262

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

589

4236

1.46

14.86

2.0

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

335

2129

1.63

14.85

2.2

nmol/l

360.8

377.8

0.79

304

1925

(3002173) Hemoglobin [Mass/volume] in Arterial blood

514

3603

1.49

14.75

6.6

7.1

g/l

125.3

120.1

6.97

498

3467

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

589

4253

1.46

14.53

2.0

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

118

3.76

14.48

1.3

1.4

u/ml

4.1

2.8

0.20

(3028026) IgM [Mass/volume] in Serum or Plasma

254

1514

1.73

14.36

1.7

1.9

g/l

1.2

1.5

0.61

224

1341

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

582

4203

1.46

14.33

10.3

8.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

108

480

2.29

14.24

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

163

865

1.92

13.48

3.5

2.6

kpa

7.6

7.8

0.79

154

785

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1380

11547

1.31

13.34

2.2

2.1

—

(3035350) Ketones [Presence] in Urine by Test strip

1635

14002

1.30

13.25

4.2

3.8

estimate

0.0

0.00

437

2588

(4062490)

192

3.00

13.15

1.4

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1369

11464

1.31

13.09

2.9

ug/l

183.4

182.1

0.05

1179

10238

(3007461) Platelets [#/volume] in Blood

3141

29459

1.41

12.99

32.8

27.1

e9/l

232.9

226.0

7.10

3039

28450

(3035941) MCH [Entitic mass]

3141

29461

1.41

12.96

32.7

27.0

30.6

30.7

0.43

3066

28807

(3026361) Erythrocytes [#/volume] in Blood

3141

29462

1.41

12.95

32.8

27.1

e12/l

4.4

1.46

3018

28325

(3024731) MCV [Entitic volume]

3141

29462

1.41

12.95

32.7

27.0

92.3

92.1

1.65

3065

28807

(3021901) Oxygen saturation in Capillary blood

144

743

1.98

12.94

3.5

2.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

3141

29468

1.41

12.88

33.0

27.3

g/l

133.1

133.9

2.20

3063

28813

(3010813) Leukocytes [#/volume] in Blood

3141

29470

1.40

12.86

32.9

27.1

e9/l

7.4

7.1

5.85

3028

28329

(3021601) Nitrite [Presence] in Urine by Test strip

1625

13943

1.29

12.84

5.3

5.1

estimate

0.0

0.00

441

2620

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

257

1585

1.67

12.81

2.2

1.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1266

10520

1.31

12.72

2.8

3.3

mmol/l

2.3

0.04

1059

8920

(3041918) Cholesterol [Moles/volume] in Pleural fluid

5.13

12.67

1.2

1.1

mmol/l

1.6

1.3

0.36

(3024139) IgG subclass 3 [Mass/volume] in Serum

191

2.96

12.66

1.3

1.2

g/l

0.5

0.4

0.40

138

(3027135) IgG subclass 1 [Mass/volume] in Serum

191

2.96

12.66

1.3

1.2

g/l

7.3

6.7

0.65

138

(3028192) IgG subclass 2 [Mass/volume] in Serum

191

2.96

12.66

1.3

1.2

g/l

3.0

0.08

140

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

239

1461

1.68

12.33

2.0

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

1643

14168

1.28

12.30

4.3

3.9

estimate

0.0

0.00

416

2499

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1233

10265

1.30

12.07

2.3

2.2

u/l

227.8

235.0

0.09

1134

9549

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

166

926

1.83

11.80

1.5

1.7

—

(3018418) pH of Serum or Plasma

1156

9570

1.30

11.73

4.1

4.0

7.4

0.12

316

1745

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2906

27061

1.33

11.47

5.8

5.6

mmol/l

2.4

1.05

2482

24163

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

191

2.85

11.47

1.6

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

283

2.50

11.46

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

283

2.50

11.46

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

283

2.50

11.46

1.6

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

192

2.84

11.36

1.6

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2795

25907

1.31

11.26

5.3

4.9

mmol/l

1.3

0.23

2371

23039

(3024980) IgG subclass 4 [Mass/volume] in Serum

322

2.39

11.25

1.4

1.5

g/l

0.8

1.0

1.12

245

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

300

1986

1.55

11.17

6.9

8.1

mmol/l

25.1

24.0

5.44

268

1816

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

125

649

1.96

11.08

1.6

iu/ml

3.8

20.6

0.88

163

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

302

2.41

10.91

1.7

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2717

25126

1.30

10.90

4.6

4.4

mmol/l

1.2

0.32

2291

22104

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

316

2.37

10.78

1.6

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2819

26212

1.30

10.75

5.3

5.0

mmol/l

4.1

4.2

1.32

2422

23522

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2881

26868

1.31

10.75

5.8

5.4

mmol/l

6.1

6.2

3.69

2459

23632

(3012095) Magnesium [Moles/volume] in Serum or Plasma

686

5332

1.35

10.73

3.2

2.9

mmol/l

0.8

0.06

628

4948

(3004588) Protein electrophoresis panel - Serum or Plasma

394

2791

1.46

10.59

2.2

2.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2807

26108

1.30

10.54

7.4

7.1

mmol/mol

41.6

0.08

2428

23509

(3007164) IgA [Mass/volume] in Serum or Plasma

522

3911

1.39

10.25

1.5

g/l

3.1

2.9

0.97

311

2204

(3026493) Urate [Moles/volume] in Serum or Plasma

1060

8807

1.28

10.16

3.4

3.1

umol/l

2012.3

7324.9

6.69

828

7372

(3047181) Lactate [Moles/volume] in Blood

190

1154

1.68

10.08

5.7

mmol/l

1.3

1.4

0.70

176

1025

(3042936) Bacteria identified in Isolate by Culture

598

4602

1.36

9.92

1.9

2.0

—

(40761535) Cells panel - Urine sediment

413

2995

1.43

9.77

3.8

3.4

—

(3000494) Fungus identified in Specimen by Culture

442

3246

1.41

9.74

1.5

1.4

—

(3020891) Body temperature

229

1471

1.59

9.73

5.0

4.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2341

21382

1.25

9.72

6.0

5.8

ug/l

3.6

4.2

0.56

1988

18851

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

101

515

1.99

9.48

1.2

1.1

u/ml

68.6

56.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

476

3558

1.39

9.45

3.7

3.0

ng/l

203.5

262.6

3.32

446

3286

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1249

10668

1.26

9.36

2.2

2.1

nmol/l

78.2

78.0

0.05

1041

9128

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

490

1.98

9.01

1.2

1.1

u/ml

6.1

0.00

(3022948) Iron [Moles/volume] in Serum or Plasma

721

5776

1.31

8.99

2.6

umol/l

12.3

12.2

0.09

642

5279

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

486

1.98

8.86

1.2

1.1

u/ml

4.4

3.2

0.17

(3004789) Transferrin [Mass/volume] in Serum or Plasma

680

5417

1.31

8.82

2.5

2.6

g/l

2.2

0.36

591

4951

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

112

607

1.87

8.81

1.7

1.3

g/l

0.2

0.22

105

576

(3009542) Hematocrit [Volume Fraction] of Blood

2487

22986

1.24

8.75

21.7

20.3

38.0

38.2

0.29

1091

13126

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

233

2.42

8.71

1.6

1.3

—

(3039000) Anion gap in Blood

145

853

1.73

8.69

5.8

6.4

mmol/l

11.3

11.5

0.45

137

760

(3018572) Chloride [Moles/volume] in Blood

145

853

1.73

8.69

5.8

6.4

mmol/l

104.6

105.4

1.15

137

760

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.77

8.58

1.1

1.2

mmol/l

0.4

2.9

0.69

(3004616) Nuclear Ab [Presence] in Serum

294

2.23

8.37

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

114

634

1.82

8.28

1.8

1.3

g/l

1.1

1.2

1.52

106

601

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

233

2.38

8.24

2.0

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1094

9311

1.25

8.23

2.4

2.3

mg/l

3.2

3.0

0.79

896

7787

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

643

5134

1.30

8.15

2.6

2.7

21.8

22.1

0.20

517

4279

(40768797) Stomach Pathology biopsy report

512

3965

1.34

8.06

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

541

4230

1.33

7.97

1.2

u/ml

2.1

2.0

0.06

129

1012

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

307

2189

1.44

7.97

1.6

1.5

—

(3037756) Immunofixation for Serum or Plasma

150

922

1.65

7.68

1.5

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

489

3788

1.33

7.67

2.3

2.5

e9/l

67.0

66.5

0.11

394

2943

(44790048)

340

2.08

7.58

1.7

1.3

—

(44790049)

340

2.08

7.58

1.7

1.3

—

(44806118)

340

2.08

7.58

1.7

1.3

—

(44790047)

340

2.08

7.58

1.7

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

206

1370

1.53

7.57

3.7

mmol/l

1.4

1.5

0.60

201

1349

(3013293) Extractable nuclear Ab [Presence] in Serum

7.35

7.55

1.5

1.4

—

(3019977) pH of Arterial blood

213

2.37

7.44

2.2

2.5

7.4

0.56

(3043409) Potassium [Moles/volume] in Arterial blood

179

1161

1.57

7.36

3.9

4.0

mmol/l

4.0

0.09

165

1073

(3017569) Oxygen content in Arterial blood

172

2.52

7.32

2.3

2.2

—

(40768804) Tissue Pathology biopsy report

1287

11271

1.22

7.16

2.5

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

581

4666

1.29

6.98

4.9

5.8

mmol/l

1.0

0.12

525

4291

(3003338) MCHC [Mass/volume]

1938

21081

0.83

6.97

30.4

25.2

g/l

331.5

332.2

3.17

1914

20819

(3027456) Digoxin [Moles/volume] in Serum or Plasma

145

908

1.62

6.93

3.4

3.0

nmol/l

0.8

0.04

112

685

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

480

1.85

6.87

2.1

2.0

mg/l

35.6

28.7

0.43

114

(1761868) Lipid panel - Serum or Plasma

819

6880

1.24

6.73

3.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

409

1.90

6.54

1.4

1.5

67.2

66.3

0.06

256

(3000850) Epithelial cells [#/volume] in Urine

902

7689

1.23

6.43

3.2

2.8

e6/l

3.3

3.2

0.06

812

6751

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

984

8464

1.22

6.42

3.5

3.1

u/l

37.4

36.3

0.16

910

7941

(3048689) Calprotectin [Mass/mass] in Stool

302

2234

1.38

6.38

1.9

2.1

ug/g

152.7

178.2

0.64

214

1720

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

468

3702

1.30

6.29

2.9

4.2

ug/l

20.7

22.8

0.09

404

3144

(3021960) Folate [Moles/volume] in Serum or Plasma

1026

8881

1.21

6.25

1.7

1.6

nmol/l

20.8

19.1

0.82

835

7505

(3021589) Normoblasts [#/volume] in Blood

1384

12346

1.19

6.06

13.3

10.4

e9/l

0.0

0.60

1169

10063

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

313

2350

1.36

6.03

1.8

1.7

—

(3017732) Neutrophils [#/volume] in Blood

254

1844

1.40

6.00

3.2

3.3

e9/l

4.1

4.4

0.78

161

1268

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

195

1350

1.47

5.96

2.7

3.4

ratio

5.5

3.6

0.25

(3014891) Appearance of Pleural fluid

4.01

5.89

1.4

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

198

1387

1.45

5.71

2.8

3.4

mg/l

43.9

53.9

0.65

152

1140

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2694

25515

1.20

5.70

20.7

17.9

ml/min/173m2

70.0

70.2

0.24

2347

21258

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

165

2.32

5.50

1.9

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

165

2.32

5.50

1.9

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

165

2.32

5.50

1.9

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

165

2.32

5.50

1.9

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

197

1389

1.44

5.50

2.8

3.4

mg/l

57.6

67.9

0.58

150

1137

(3044927) Protein electrophoresis panel - Urine

457

1.77

5.45

1.5

1.2

—

(3011412) CD3 cells [#/volume] in Blood

226

2.09

5.33

2.0

2.1

e9/l

1.0

1.1

0.10

137

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

125

2.49

5.28

2.0

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

125

2.49

5.28

2.0

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

150

2.35

5.23

1.4

3.7

3.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

448

3611

1.27

5.20

5.9

6.6

mmol/l

11.4

11.8

0.60

414

3393

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

142

953

1.51

5.11

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

127

832

1.54

5.10

1.4

1.5

ug/g

271.9

251.3

0.58

523

(3007930) Methemoglobin/Hemoglobin.total in Blood

223

1631

1.39

5.09

4.8

4.9

0.9

1.19

211

1528

(46235355) HIV 1 and 2 tests - Meaningful Use set

310

2387

1.33

5.08

1.3

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.66

5.07

1.6

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

319

2473

1.32

4.99

3.1

2.9

ml/min/173m2

55.1

58.6

1.14

142

1053

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

274

2078

1.34

4.98

9.1

8.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

454

3690

1.26

4.91

2.9

2.4

ug/l

6.0

7.0

0.85

385

3200

(44813793)

100

2.61

4.88

1.1

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

225

1665

1.37

4.80

4.8

1.7

1.6

1.70

214

1559

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1584

14492

1.16

4.74

2.3

2.2

pmol/l

92.7

90.3

1.20

876

8111

(4035726)

324

2536

1.30

4.73

1.4

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

127

2.37

4.64

2.1

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

253

1.95

4.63

1.1

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

590

4987

1.22

4.44

2.3

1.7

0.28

499

4328

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

315

2480

1.29

4.42

1.6

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

245

1866

1.33

4.36

2.6

2.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

273

1.88

4.35

1.1

1.2

u/l

54.6

68.4

0.79

167

(21494814) CD8 cells/100 lymphocytes in Specimen

2.66

4.32

2.3

2.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

378

1.73

4.25

2.8

3.1

—

(4146454)

431

1.68

4.24

2.1

2.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1547

14214

1.15

4.21

4.4

4.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

328

1.78

4.17

1.4

26.3

23.3

0.26

209

(3037121) Protein [Mass/volume] in Urine

170

1231

1.40

4.17

2.8

2.9

g/l

0.4

0.3

0.27

525

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

160

2.14

4.15

2.0

2.1

17.9

16.2

—

(3026782) Osmolality of Urine

824

7229

1.18

4.11

3.2

3.0

mosm/kgh2o

556.6

579.2

2.46

725

6140

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.36

4.08

1.3

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.76

4.08

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

244

1.90

4.06

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

239

1.89

3.96

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

394

3233

1.24

3.94

6.3

6.2

mmol/l

1.4

0.21

382

3086

(21494815) CD4 cells/100 lymphocytes in Specimen

177

2.04

3.94

2.3

2.1

40.1

40.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

131

2.22

3.92

1.2

1.1

u/ml

0.7

1.5

—

(36660697) Celiac disease serology panel - Serum

198

1486

1.35

3.92

1.1

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

292

1.79

3.86

1.3

1.4

—

(3004451) EKG impression Narrative

193

1.98

3.82

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

2.84

3.79

1.1

u/ml

0.5

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

363

2966

1.25

3.78

2.2

2.1

g/l

0.2

1.13

320

2717

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.74

3.75

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.74

3.75

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.74

3.75

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.74

3.75

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

145

1043

1.41

3.73

2.8

3.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

103

2.34

3.66

1.0

1.1

—

(3016228) CD19 cells/100 cells in Blood

2.43

3.63

2.4

2.0

7.9

5.0

0.39

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

428

1.62

3.60

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1321

0.67

3.57

2.8

3.4

u/ml

85.4

3171.2

0.90

1140

(3002523) Influenza virus A Ag [Presence] in Specimen

105

2.29

3.52

1.0

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

622

1.51

3.51

4.4

3.4

1.0

1.7

1.10

455

(3017354) Segmented neutrophils/100 leukocytes in Blood

385

1.65

3.49

4.5

3.3

57.3

59.5

0.29

229

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

440

1.60

3.47

1.5

1.4

—

(3048879) Bone marrow aspiration report

125

2.17

3.47

2.1

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

300

2428

1.26

3.41

3.8

4.0

ng/l

97.8

106.2

0.80

245

2079

(3044889) 12 lead EKG panel

2170

20564

1.13

3.40

5.6

4.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

404

1.62

3.38

5.9

3.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

148

2.04

3.30

1.1

u/l

127.6

98.1

0.49

111

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

148

2.04

3.30

1.1

u/l

40.3

39.4

0.02

108

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

149

2.02

3.25

1.9

2.0

e9/l

0.2

0.03

135

(3024891) Influenza virus A+B Ag [Presence] in Specimen

577

1.50

3.23

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

279

1.73

3.22

1.3

1.1

u/ml

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

619

1.48

3.20

1.4

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

654

5750

1.17

3.13

1.8

1.9

30.8

30.4

0.63

627

5576

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

248

1985

1.27

3.12

1.3

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

445

1.56

3.11

2.8

3.6

—

(3012516) Albumin [Mass/volume] in Urine

1198

10991

1.13

3.10

3.4

3.3

mg/l

628.7

320.4

1.07

764

7459

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

640

1.46

3.10

1.2

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

175

1342

1.32

3.06

2.2

ug/l

388.8

597.5

0.83

155

1279

(3014271) Vancomycin [Susceptibility]

232

1.78

3.03

3.1

3.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

379

1.59

2.97

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

379

1.59

2.97

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

379

1.59

2.97

1.3

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

2.55

2.95

1.1

u/ml

5.0

0.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

380

1.59

2.94

1.3

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.15

2.93

1.4

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

213

1.79

2.91

1.4

1.1

u/ml

125.8

51.0

—

(3003181) Sodium [Moles/volume] in Urine

558

1.48

2.91

1.5

1.3

mmol/l

60.3

64.2

0.38

450

(3026008) Bacteria identified in Urine by Culture

1032

9415

1.13

2.89

3.3

3.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

250

2023

1.25

2.89

1.4

1.5

—

(3022145) Colonoscopy Study observation

380

3212

1.20

2.89

1.4

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

288

2368

1.23

2.88

1.6

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

110

793

1.40

2.87

2.5

2.6

mg/l

1.8

0.10

680

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

391

1.57

2.85

1.2

1.4

—

(40768443) Skin Pathology biopsy report

173

1343

1.30

2.80

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.40

2.79

1.3

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

166

1.87

2.75

1.7

2.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

162

1252

1.31

2.72

1.2

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

160

1.88

2.70

1.9

2.0

e6/l

553.3

522.1

0.12

137

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

446

1.51

2.67

1.2

1.1

—

(36304419) Bacteria [Presence] in Urine

1009

9233

1.13

2.67

3.8

3.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.33

2.65

2.3

2.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

794

7164

1.14

2.63

1.7

1.6

mmol/l

1.3

0.35

593

5843

(3009508) Creatinine [Moles/volume] in Urine

1188

10986

1.12

2.62

3.3

mmol/l

7.6

7.7

0.51

932

8932

(3024522) Salmonella sp identified in Specimen by Organism specific culture

384

1.55

2.61

1.3

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.16

2.60

1.5

1.3

umol/l

77.9

67.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

171

1.82

2.54

2.3

2.0

e6/l

606.3

576.8

0.07

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.23

2.53

2.0

2.1

—

(3021788) Differential panel - Synovial fluid

602

1.42

2.50

1.5

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

1064

9801

1.12

2.49

3.8

3.5

e6/l

0.6

0.5

0.65

856

7665

(3025941) Bacteria identified in Stool by Culture

163

1284

1.28

2.40

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

101

743

1.37

2.39

2.4

2.3

umol/l

32.1

33.4

0.12

595

(3009214) Lutropin [Units/volume] in Serum or Plasma

435

1.48

2.35

1.4

1.3

u/l

11.4

8.6

1.26

345

(3017704) Immunofixation for Urine

260

1.62

2.32

1.7

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

2.86

2.30

1.0

1.1

—

0.4

—

(3044640) Blood type and Crossmatch panel - Blood

1090

10098

1.11

2.28

2.6

2.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

185

1.74

2.27

2.3

2.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

163

1.79

2.26

1.3

1.6

u/l

6.4

8.9

—

(3006462) Nitrate [Presence] in Urine

157

1.79

2.21

4.1

3.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1248

11660

1.11

2.20

4.2

4.1

mg/mmol

11.9

9.5

0.86

787

7761

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.62

2.18

1.4

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

182

1.71

2.11

1.0

1.2

promille

1.0

1.2

0.22

144

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.71

2.10

5.2

4.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

116

892

1.31

2.09

1.2

1.1

iu/ml

63.4

109.1

1.26

269

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

107

814

1.32

2.08

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

249

2095

1.20

2.06

1.4

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.00

2.04

3.5

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

2223

21402

1.09

2.02

25.6

22.5

14.2

14.0

9.95

2173

20850

(3049717) Cytology report of Urine Cyto stain

256

2164

1.20

2.01

3.4

3.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.64

2.01

1.7

1.5

umol/l

45.1

46.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

431

3803

1.15

2.00

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

296

1.53

1.97

1.1

1.3

pmol/l

204.1

248.8

0.87

222

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

179

1.68

1.95

1.1

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.55

1.94

1.0

1.5

—

(3018095) Leukocytes [#/volume] in Urine

1263

11887

1.09

1.86

4.4

4.1

e6/l

125.3

106.0

0.25

998

9105

(3003327) Ova and parasites identified in Stool by Light microscopy

594

1.35

1.86

2.0

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.40

1.85

2.0

2.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

175

1.66

1.82

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

175

1.66

1.82

1.4

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

186

1546

1.21

1.78

1.2

—

(4211845)

177

1.64

1.76

4.0

3.3

—

(3000991) Gas panel - Venous blood

357

3143

1.15

1.73

7.7

7.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.67

1.72

2.9

1.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.85

1.71

1.0

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

1154

10853

1.09

1.71

4.0

3.6

e6/l

153.0

127.1

0.13

946

8687

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

522

5764

0.89

1.71

3.6

3.4

e6/l

1.2

1.0

0.21

310

3494

(3014765) Yersinia sp identified in Stool by Organism specific culture

726

1.30

1.70

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

238

2037

1.18

1.67

3.5

3.4

mmol/l

25.8

24.7

4.39

227

1971

(42529406) Shigella sp [Presence] in Stool by Culture

728

1.30

1.67

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

451

1.38

1.67

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

554

1.34

1.66

8.3

4.5

iu/ml

768.9

4651.8

0.67

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

246

2113

1.18

1.66

1.6

1.7

g/l

1.5

0.30

207

1798

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.86

1.66

1.2

ug/l

8.4

8.9

0.08

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

721

1.30

1.64

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

231

1.52

1.56

6.6

13.2

—

(3028433) Virus identified in Specimen by Culture

1.86

1.50

1.0

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

631

5810

1.10

1.47

35.9

32.3

inr

1.6

1.5

0.34

802

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.81

1.47

2.1

2.2

—

(3016038) Potassium [Moles/volume] in Urine

220

1.50

1.43

1.1

mmol/l

38.0

35.6

0.24

191

(3043410) Blood group antigens tested for on Red Blood Cells

1.79

1.43

1.3

2.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

254

1.46

1.40

1.5

1.3

nmol/l

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.18

1.39

2.1

—

(3019150) Specific gravity of Urine by Refractometry

699

6485

1.10

1.39

4.9

4.3

kg/l

1.0

0.10

102

1014

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.42

1.39

1.0

1.2

—

(3020650) Glucose [Presence] in Urine

2.13

1.33

1.6

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

497

1.31

1.32

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.78

1.28

1.0

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

132

0.45

1.28

1.3

1.2

mmol/l

5.8

6.4

—

126

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

252

1.43

1.26

1.1

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

189

0.53

1.22

1.3

1.4

umol/l

17.1

15.7

—

175

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

126

1054

1.20

1.21

2.4

2.3

ug/min

108.9

100.5

0.14

608

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

234

2059

1.15

1.21

1.6

1.7

0.18

186

1636

(3008898) HLA-B27 [Presence]

365

1.35

1.21

1.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.80

1.21

1.1

1.2

21.0

32.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

230

1.44

1.19

1.4

1.5

—

1588.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.83

1.19

1.0

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

154

1317

1.18

1.17

2.2

2.4

g/l

1.3

0.02

124

1099

(21494755) Public health laboratory ask at order entry panel

356

0.67

1.14

1.5

1.4

—

(40768441) Liver Pathology biopsy report

166

1.51

1.14

1.2

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

732

6867

1.08

1.14

5.3

4.2

ng/l

180.4

638.9

3.15

644

6153

(3001019) Free T4 and TSH panel - Serum or Plasma

222

0.58

1.13

2.2

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

816

1.22

1.13

1.2

—

(3002032) Base excess in Venous blood by calculation

405

3703

1.11

1.12

4.2

3.7

mmol/l

2.6

1.6

6.13

335

2892

(3002256) Pathology report gross observation

459

4224

1.10

1.11

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

171

1484

1.16

1.10

2.3

g/l

10.5

10.3

0.33

137

1225

(3000475) Leukocytes [#/volume] in Synovial fluid

100

828

1.21

1.09

1.5

1.6

e6/l

12325.0

18404.5

1.10

580

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

801

1.22

1.09

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

801

1.22

1.09

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

405

3709

1.10

1.09

4.2

3.7

kpa

6.0

5.8

4.31

392

3581

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

129

1095

1.18

1.09

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.82

1.09

1.9

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

726

0.78

1.07

1.9

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

168

1460

1.16

1.06

2.3

g/l

3.0

3.1

0.08

123

1113

(3008295) Osmolality of Serum or Plasma

296

1.36

1.06

1.6

1.3

mosm/kgh2o

271.6

278.8

1.06

213

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

760

1.22

1.04

3.2

u/ml

1643.0

931.2

0.28

702

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.27

1.03

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.27

1.03

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.27

1.03

1.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

252

0.63

1.03

1.1

1.2

mmol/l

7.7

7.8

—

185

(3014576) Chloride [Moles/volume] in Serum or Plasma

516

4794

1.09

1.03

7.2

6.5

mmol/l

104.1

104.7

2.19

497

4674

(3033799) Differential panel - Peritoneal fluid

1.64

1.03

1.6

2.1

—

(3011985) Renin [Units/volume] in Plasma

324

1.33

1.02

1.3

mu/l

66.3

70.3

0.05

284

(3036489) Thrombin time

1018

0.82

1.02

1.6

1.9

20.8

22.0

1.73

935

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.88

1.00

1.0

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

322

2931

1.11

0.99

2.1

nmol/l

11.7

11.5

0.22

258

2459

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

343

1.32

0.99

1.1

1.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

815

7721

1.07

0.98

2.5

2.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

667

6275

1.08

0.98

2.8

3.2

mmol/l

2.5

1.68

587

5442

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.97

0.0

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.95

0.97

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.96

0.0

8.5

—

7.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

224

1.39

0.96

1.2

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

269

2432

1.11

0.95

3.5

3.4

g/l

129.3

127.1

0.91

262

2362

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.69

0.95

1.3

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

652

1.22

0.93

1.5

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

481

1.25

0.92

25.4

23.6

mmol/l

8.0

7.6

0.30

377

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1.67

0.91

1.2

1.3

u/l

23.2

17.3

0.34

(3035637) Corticotropin [Mass/volume] in Plasma

296

1.32

0.90

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

160

1.44

0.88

1.3

nmol/l

1.4

1.1

0.67

115

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

431

1.26

0.87

3.0

2.3

u/ml

350.0

3049.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

264

1.33

0.86

1.5

1.3

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.94

0.84

1.7

2.2

50.0

64.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

118

1022

1.16

0.83

1.6

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

129

1.48

0.83

1.0

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

245

2694

0.90

0.83

3.0

2.4

u/l

32.8

35.2

0.50

199

2267

(3045424) Erythrocytes [Presence] in Urine

472

1.23

0.81

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

179

1601

1.12

0.80

2.3

2.2

g/l

7.6

7.3

1.12

127

1134

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

179

1601

1.12

0.80

2.3

2.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

198

1.37

0.80

1.0

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.5

—

0.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.79

0.0

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

657

1.19

0.78

1.2

u/l

25.4

42.4

2.01

576

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

165

1.40

0.77

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.77

0.0

1.1

—

1.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

123

1.47

0.77

1.9

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

123

1.47

0.77

1.9

2.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

125

0.56

0.77

1.0

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

806

1.17

0.77

1.1

titre

83.0

260.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

217

1.34

0.76

1.4

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

157

1.40

0.76

1.0

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

178

1597

1.12

0.76

2.3

2.2

g/l

4.0

3.8

0.39

124

1097

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

136

1200

1.14

0.76

2.1

g/l

37.2

37.0

0.17

113

1003

(3042733) HLA Ab [Presence] in Serum

1.70

0.75

5.3

5.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.70

0.75

1.1

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

725

1.18

0.74

1.3

1.5

—

(3022621) pH of Urine by Test strip

192

2123

0.90

0.74

3.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

125

1.44

0.72

1.2

g/l

42.7

41.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

784

1.16

0.71

1.1

—

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.92

0.70

1.2

—

(21494434) Karyotype in Bone marrow

381

1.24

0.70

1.1

1.2

—

(4133840)

1.55

0.69

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

579

6096

0.94

0.69

3.3

3.1

e6/l

1.3

1.0

1.02

366

3788

(3052592) Norovirus Ag [Presence] in Stool

1.56

0.68

1.3

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

127

1.42

0.67

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

383

1.23

0.67

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

214

0.70

0.66

2.7

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

1.41

0.65

1.0

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

403

1.22

0.65

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.54

0.65

1.0

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

1.67

0.61

1.2

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

769

1.15

0.60

1.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.60

0.0

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

334

0.78

0.60

2.7

3.5

mg/l

24.8

31.4

0.23

270

(3016750) Collection duration of Urine

227

1.28

0.59

2.0

min

488.3

493.7

0.09

155

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.59

0.0

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.56

0.58

1.7

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.46

0.58

1.4

2.2

mmol/l

6.8

7.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

114

0.61

0.58

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

123

1.38

0.57

1.1

1.6

—

(3045414) Leukocytes [Presence] in Urine

143

1295

1.11

0.57

2.1

1.9

—

(3001729) Color of Synovial fluid

1.67

0.56

1.0

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

365

1.21

0.56

1.1

1.0

—

(3033658) Prothrombin time (PT) actual/Normal

746

7744

0.95

0.55

4.5

4.1

77.7

79.2

0.88

724

7560

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

197

1817

1.09

0.54

3.4

2.6

0.6

0.7

0.22

190

1741

(3006442) Creatine [Moles/volume] in Serum or Plasma

177

1.30

0.54

3.0

1.7

—

72.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

116

1.38

0.54

1.8

1.5

g/l

1.1

0.9

1.25

116

(3020876) Protein [Mass/time] in 24 hour Urine

367

1.20

0.54

2.3

1.9

—

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

160

1.31

0.53

3.0

2.8

33.4

33.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

555

0.84

0.52

2.0

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.43

0.52

1.3

1.7

ng/l

122.4

186.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.43

0.52

1.1

—

(3045142) Bone marrow Pathology biopsy report

424

1.18

0.52

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

133

0.68

0.51

1.1

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

305

1.22

0.51

2.2

1.8

mu/l

218.0

295.6

2.84

285

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

162

1.30

0.50

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

127

1.34

0.49

1.2

—

(1002224) Polysomnography panel

519

0.85

0.49

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

518

0.85

0.48

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1749

17180

1.03

0.47

5.3

5.0

21.0

22.2

3.18

970

9501

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

120

1.33

0.46

1.3

1.1

—

(3015183) Erythrocyte sedimentation rate

1.43

0.46

1.0

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

1.38

0.46

43.1

23.3

ug/l

155.1

110.4

1.36

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.40

0.45

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

186

0.75

0.44

1.1

—

127.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.37

0.44

1.1

1.0

—

(3004775) Volume in Urine collected for unspecified duration

358

1.18

0.43

2.2

654.0

663.6

0.05

215

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

166

1.27

0.43

2.3

—

(3024869) Neuronal Ab [Presence] in Serum

1.41

0.43

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

317

0.82

0.42

1.9

2.1

u/field

1.6

1.5

—

106

(3024932) HLA-DR beta [Type]

1.43

0.42

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.43

0.42

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.56

0.42

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.63

0.42

1.5

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

139

0.72

0.41

1.0

1.2

—

(4024509)

295

1.19

0.41

1.6

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.41

0.0

1.2

—

(40758558) Short blood count panel - Blood

736

7138

1.04

0.41

5.9

6.2

—

(3024471) HLA-A [Type]

1.36

0.41

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

2.9

—

113.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

352

1.17

0.40

1.3

e6/l

102630.5

204885.1

0.46

252

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.4

—

346.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

421

0.85

0.39

1.7

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.39

0.0

8.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

124

1.29

0.38

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

124

1.29

0.38

1.0

—

(4281824)

151

1.26

0.38

1.4

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

484

0.87

0.38

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.39

0.38

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.34

0.38

1.1

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

345

1.16

0.37

1.1

1.2

u/ml

355.7

289.0

0.78

206

(3006653) Thiamine [Moles/volume] in Blood

143

1.26

0.36

1.0

1.1

nmol/l

135.1

136.7

0.07

143

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

116

0.69

0.36

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

179

1906

0.94

0.36

4.0

3.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

319

3048

1.05

0.36

3.6

3.1

kpa

4.6

4.4

0.58

309

2929

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.64

0.35

1.2

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

200

0.80

0.34

1.1

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

200

0.80

0.34

1.1

1.3

—

(40768446) Kidney Pathology biopsy report

1.34

0.34

1.6

1.7

—

(4094501)

711

1.10

0.33

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.69

0.33

1.0

1.6

239.2

196.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

483

1.12

0.32

1.8

pmol/l

175.0

192.8

0.82

435

(3003694) ABO and Rh group [Type] in Blood

690

7081

0.97

0.31

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

475

1.12

0.31

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.29

0.30

1.3

1.1

—

(3011288) Drugs identified in Urine by Screen method

1.23

0.29

1.0

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

662

6783

0.97

0.28

4.5

3.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

167

1.20

0.28

1.3

1.2

—

(3016879) Cocaine [Presence] in Urine

1.32

0.28

1.0

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.27

0.27

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.27

0.27

1.8

1.3

ug/l

0.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.27

0.27

1.0

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

384

1.12

0.27

1.2

1.4

u/ml

120.2

129.1

0.19

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

117

0.77

0.27

1.6

3.5

u/ml

25.9

27.1

—

112

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.23

0.27

2.6

1.4

ug/l

9.7

10.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

186

1772

1.05

0.26

4.7

4.0

mmol/l

24.5

23.8

2.55

165

1562

(40768800) Prostate Pathology biopsy report

141

1491

0.94

0.26

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

395

1.12

0.26

1.4

1.5

iu/l

4.0

4.1

0.01

107

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.30

0.26

1.2

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.68

0.26

1.0

1.1

—

(4034850)

924

0.93

0.26

20.1

13.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

224

0.85

0.25

1.0

1.1

—

64.0

—

(3000764) Benzodiazepines [Presence] in Urine

1.22

0.25

1.0

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

105

1.24

0.24

1.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

1.18

0.24

1.0

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

108

1016

1.06

0.24

3.8

3.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

455

1.10

0.24

2.2

2.0

—

(3027008) Opiates [Presence] in Urine

1.28

0.24

1.0

1.4

—

(3022689) Creatine [Moles/volume] in Urine

0.71

0.24

1.7

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.28

0.23

1.2

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

400

0.90

0.22

2.8

3.6

nmol/l

10.6

9.4

0.10

393

(3044007) Cell count panel - Peritoneal fluid

0.77

0.22

2.6

2.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.25

0.22

1.0

1.2

—

8.0

—

(4027681)

0.75

0.22

1.1

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

0.75

0.22

1.0

1.8

—

(3028300) Cannabinoids [Presence] in Urine

1.27

0.22

1.0

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

1.22

0.22

1.0

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

586

0.92

0.21

2.6

2.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

6.9

—

41.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.21

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

38.9

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

258

1.12

0.21

1.3

1.4

—

158.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.16

0.21

1.0

1.4

—

(40765096) Chromosome analysis panel by Banding

126

1.19

0.21

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.21

0.0

2.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.2

—

(3024263) Appearance of Synovial fluid

192

1.15

0.20

1.4

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

120

1141

1.05

0.20

2.2

g/l

0.0

0.1

1.85

110

1023

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

0.00

0.20

0.0

1.1

—

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

110

1044

1.06

0.20

2.2

2.3

g/l

0.0

0.00

102

941

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

355

0.90

0.20

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

221

1.13

0.20

2.4

2.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.22

0.20

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

0.83

0.19

1.2

1.1

—

(40768793) Breast Pathology biopsy report

165

0.85

0.19

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

364

0.91

0.19

4.0

3.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

569

1.07

0.19

2.6

1.3

nmol/l

0.9

0.8

0.19

459

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.13

0.18

11.5

11.9

mmol/l

4.1

5.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

539

0.93

0.18

1.2

1.3

e6/l

10.2

30.9

0.85

426

(3000012) Reticulocyte production index

242

1.12

0.18

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

338

1.10

0.18

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

538

0.93

0.17

1.3

1.4

e6/l

239.9

926.7

1.45

443

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

310

0.90

0.17

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

138

1.16

0.17

1.1

1.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

160

1541

1.04

0.17

2.3

2.6

u/ml

0.3

0.03

858

(3016018) Differential panel - Cerebral spinal fluid

224

1.12

0.17

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

504

1.07

0.17

1.4

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.75

0.17

5.4

8.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

111

1061

1.05

0.17

2.3

2.2

g/l

0.0

0.28

102

946

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

456

1.08

0.16

1.2

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

215

1.12

0.16

1.3

2.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

447

1.07

0.16

1.9

1.6

mg/l

11.7

2.5

1.62

323

(3006270) Folate [Moles/volume] in Blood

312

1.09

0.15

1.4

1.3

nmol/l

270.6

315.0

0.89

226

(3011648) Oxygen content in Venous blood

235

1.11

0.15

2.7

1.8

11.5

10.7

0.31

235

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.13

0.15

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

556

1.06

0.15

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.80

0.14

5.9

9.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

508

1.06

0.14

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

198

1.11

0.14

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

227

1.10

0.14

1.1

—

8.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

353

1.08

0.14

1.1

iu/ml

38.0

569.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1192

12029

0.99

0.14

3.6

3.4

ug/l

0.8

1.02

874

8951

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

363

1.08

0.13

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

305

1.08

0.13

1.4

1.7

u/ml

29.4

27.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

373

1.07

0.13

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

253

0.91

0.13

1.2

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

180

0.89

0.13

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

0.85

0.13

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

108

1042

1.04

0.12

3.9

3.3

pmol/l

4.2

4.3

0.46

891

(3044941) Cell count panel - Synovial fluid

502

1.06

0.12

1.5

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

791

0.96

0.11

3.7

mg/l

25.1

33.6

1.22

530

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.16

0.11

1.2

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

163

1.10

0.10

1.4

pmol/l

91.2

54.6

0.55

(4306422)

241

1.08

0.10

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.15

0.10

2.2

2.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.14

0.10

1.0

1.1

—

(3051651) Icteric interference index of Serum or Plasma

197

0.91

0.09

5.2

3.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.11

0.09

3.2

1.7

pmol/l

44.4

36.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

271

1.07

0.09

1.0

1.2

u/ml

5.5

5.3

0.02

123

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.09

0.09

1.0

—

(3012565) Volume of 24 hour Urine

145

1.10

0.09

1.6

2.4

2283.6

1916.9

0.75

116

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.04

0.09

1.2

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

134

0.90

0.08

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

206

0.92

0.08

1.3

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.05

0.08

1.0

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.05

0.08

1.0

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.03

0.08

1.0

1.3

110.7

84.0

—

(3000285) Sodium [Moles/volume] in Blood

0.82

0.08

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.83

0.08

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

627

1.04

0.08

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

113

1159

0.97

0.08

4.0

4.4

—

(3029075) Extractable nuclear Ab panel - Serum

0.78

0.08

1.2

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.04

0.08

1.3

1.4

g/l

31.5

25.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

127

1.10

0.07

2.7

2.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.03

0.07

3.0

1.3

—

(3024928) Oxygen saturation in Venous blood

783

0.97

0.07

3.2

3.1

—

(40757373) Influenza virus identified in Isolate

1.05

0.07

2.8

1.4

—

(3013727) Leukocytes other/100 leukocytes in Blood

143

0.91

0.07

4.5

3.5

61.5

53.2

0.92

137

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

184

0.92

0.07

1.6

1.8

u/field

0.6

2.9

—

122

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.85

0.07

1.3

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

570

1.04

0.07

1.4

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

346

3423

1.01

0.06

3.1

2.7

umol/l

11.2

10.4

0.25

306

3035

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

105

0.86

0.06

5.0

9.1

—

(3025577) Chromium [Mass/volume] in Blood

306

1.05

0.05

2.1

2.0

ug/l

1.5

2.2

1.61

250

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

181

0.94

0.05

1.1

—

(44806420)

160

1.06

0.04

2.2

2.5

—

(3036603) Volume of Urine

200

1.05

0.03

1.3

1.7

2174.8

1821.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

181

1.05

0.03

1.1

1.0

u/ml

4.9

2.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

132

1.06

0.02

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

132

1.06

0.02

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

132

1.06

0.02

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

278

0.97

0.02

1.0

1.2

u/ml

1.8

2.9

0.64

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

127

0.94

0.01

3.3

2.6

—

(3014051) Protein [Presence] in Urine by Test strip

701

1.01

0.01

2.6

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

143

1.05

0.01

1.1

—

(3045716) Anion gap in Serum or Plasma

173

1.04

0.01

1.4

2.3

mmol/l

7.6

9.4

1.27

135

(4268621)

177

0.96

0.01

1.6

2.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.04

0.00

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.04

0.00

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.04

0.00

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

204

1.03

0.00

4.1

3.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

132

0.98

0.00

2.2

1.6

nmol/l

15.3

13.3

0.39

118

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

172

0.99

0.00

4.1

2.0

—

(40768795) Lymph node Pathology biopsy report

262

0.99

0.00

1.3

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

125

1.04

0.00

1.1

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

175

1.03

0.00

1.1

—

3.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

246

1.02

0.00

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

277

1.01

0.00

1.5

1.2

nmol/l

1.4

1.5

0.19

243

(3038177) Helicobacter pylori Ab [Presence] in Serum

263

0.99

0.00

1.3

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

3.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

6.4

—

(3013762) Body weight Measured

0.00

0.0

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.00

0.00

1.0

1.1

—

0.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

8.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.0

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.1

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.1

—

59.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.00

0.00

1.0

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.4

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.96

0.00

1.2

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.89

0.00

12.6

7.2

14.7

13.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.4

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

100

1.00

0.00

3.6

6.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.90

0.00

1.0

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.0

—

2.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.9

—

338.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.4

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

170

1.00

0.00

2.1

2.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_PLEURPLAGUE and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_PLEURPLAGUE	1.23 [1.1, 1.37]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.658

During the follow-up period (1.1.1998 — 31.12.2019), 1033 out of 2963 females with J10_PLEURPLAGUE died.

Males

Parameter	HR [95% CI]	p-value
J10_PLEURPLAGUE	1.37 [1.26, 1.49]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 7086 out of 17328 males with J10_PLEURPLAGUE died.

Mortality risk

Mortality risk for people of age

years, who have J10_PLEURPLAGUE.

N-year risk	Females	Males
1	0.142%	0.227%
5	0.715%	1.345%
10	1.869%	3.572%
15	3.924%	6.586%
20	7.039%	11.352%

Relationships between endpoints

↥

Index endpoint: J10_PLEURPLAGUE – Pleural plaque

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pleural plaque

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints